MMV is seeking to fill the following posts to join our dedicated team:

Deadline: 30 November 2014
Deadline: 04 January 2015
Deadline: 05 January 2015

John's story

Even doctors get malaria

Dr. John Amuasi is a Senior Research Fellow at the Kumasi Collaborative Centre for Research in Tropical Medicine in Ghana.

Partner interview

Masahiko Koike, Director, Pharmaceutical Technology R&D Laboratories, Takeda, explains how the company is contributing to two exciting antimalarial drug projects and what it’s like to work with MMV.

Latest science article

Lead clinical and pre-clinical antimalarial drugs can significantly reduce sporozoite transmission to vertebrate populations.


Collaborations set to advance life-saving pre-referral treatment for severe malaria

27 November 2014
Roll Back Malaria logo

RBM seeks input for the second Global Malaria Action Plan

20 November 2014

Coartem® Dispersible was developed by Novartis and MMV to change the way children with malaria are treated

19 November 2014

Recognition of project in collaboration with MMV and DNDi to optimize new compounds for parasitic diseases

13 November 2014

First delivery of this life-saving drug made through MMV-led UNITAID-funded "Improving Severe Malaria Outcomes" project

04 November 2014